A detailed history of Catalyst Capital Advisors LLC transactions in Insulet Corp stock. As of the latest transaction made, Catalyst Capital Advisors LLC holds 363 shares of PODD stock, worth $101,088. This represents 0.0% of its overall portfolio holdings.

Number of Shares
363
Holding current value
$101,088
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025

BUY
$227.79 - $275.7 $82,687 - $100,079
363 New
363 $94,000
Q1 2020

May 12, 2020

SELL
$130.01 - $216.44 $962,073 - $1.6 Million
-7,400 Closed
0 $0
Q4 2019

Feb 06, 2020

BUY
$144.81 - $186.0 $1.07 Million - $1.38 Million
7,400 New
7,400 $1.27 Million

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $19.3B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Catalyst Capital Advisors LLC Portfolio

Follow Catalyst Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalyst Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Catalyst Capital Advisors LLC with notifications on news.